These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9351178)

  • 1. Pathogenesis of dengue virus diseases: missing pieces in the jigsaw.
    Bielefeldt-Ohmann H
    Trends Microbiol; 1997 Oct; 5(10):409-13. PubMed ID: 9351178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dengue hemorrhagic fever with special emphasis on immunopathogenesis.
    Kurane I
    Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):329-40. PubMed ID: 17645944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection.
    Noisakran S; Perng GC
    Exp Biol Med (Maywood); 2008 Apr; 233(4):401-8. PubMed ID: 18367628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage.
    Lin CF; Lei HY; Shiau AL; Liu CC; Liu HS; Yeh TM; Chen SH; Lin YS
    J Med Virol; 2003 Jan; 69(1):82-90. PubMed ID: 12436482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the relationship between antibody-dependent enhancement and immunological distance with application to dengue.
    Adams B; Boots M
    J Theor Biol; 2006 Sep; 242(2):337-46. PubMed ID: 16631802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection.
    Guzman MG; Alvarez M; Halstead SB
    Arch Virol; 2013 Jul; 158(7):1445-59. PubMed ID: 23471635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development in the analysis of the pathogenesis of dengue hemorrhagic fever, and current status of dengue vaccine].
    Kurane I
    Uirusu; 2002 Jun; 52(1):15-20. PubMed ID: 12227165
    [No Abstract]   [Full Text] [Related]  

  • 8. A re-evaluation of the mechanisms leading to dengue hemorrhagic fever.
    Noisakran S; Chokephaibulkit K; Songprakhon P; Onlamoon N; Hsiao HM; Villinger F; Ansari A; Perng GC
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E24-35. PubMed ID: 19751399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue immune response: low affinity, high febrility.
    Welsh RM; Rothman AL
    Nat Med; 2003 Jul; 9(7):820-2. PubMed ID: 12835692
    [No Abstract]   [Full Text] [Related]  

  • 10. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.
    Mongkolsapaya J; Dejnirattisai W; Xu XN; Vasanawathana S; Tangthawornchaikul N; Chairunsri A; Sawasdivorn S; Duangchinda T; Dong T; Rowland-Jones S; Yenchitsomanus PT; McMichael A; Malasit P; Screaton G
    Nat Med; 2003 Jul; 9(7):921-7. PubMed ID: 12808447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathological mechanisms in dengue and dengue hemorrhagic fever.
    Green S; Rothman A
    Curr Opin Infect Dis; 2006 Oct; 19(5):429-36. PubMed ID: 16940865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity.
    Koraka P; Murgue B; Deparis X; Setiati TE; Suharti C; van Gorp EC; Hack CE; Osterhaus AD; Groen J
    J Med Virol; 2003 May; 70(1):91-8. PubMed ID: 12629649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding dengue pathogenesis: implications for vaccine design.
    Stephenson JR
    Bull World Health Organ; 2005 Apr; 83(4):308-14. PubMed ID: 15868023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever.
    Wang WK; Chen HL; Yang CF; Hsieh SC; Juan CC; Chang SM; Yu CC; Lin LH; Huang JH; King CC
    Clin Infect Dis; 2006 Oct; 43(8):1023-30. PubMed ID: 16983615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection of dengue 2 virus strains isolated from patients exhibiting different disease severities to human peripheral blood leukocytes and production of cytokines in the infected culture supernatant.
    Soemanto BE; Hasebe F; Igarashi A
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):729-34. PubMed ID: 10928367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever.
    Fink J; Gu F; Vasudevan SG
    Rev Med Virol; 2006; 16(4):263-75. PubMed ID: 16791836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies determine virulence in dengue.
    Halstead SB
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E48-56. PubMed ID: 19751402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia.
    Porter KR; Beckett CG; Kosasih H; Tan RI; Alisjahbana B; Rudiman PI; Widjaja S; Listiyaningsih E; Ma'Roef CN; McArdle JL; Parwati I; Sudjana P; Jusuf H; Yuwono D; Wuryadi S
    Am J Trop Med Hyg; 2005 Jan; 72(1):60-6. PubMed ID: 15728868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue plasminogen activator induced by dengue virus infection of human endothelial cells.
    Huang YH; Lei HY; Liu HS; Lin YS; Chen SH; Liu CC; Yeh TM
    J Med Virol; 2003 Aug; 70(4):610-6. PubMed ID: 12794725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in understanding dengue virus replication.
    Urcuqui-Inchima S; Patiño C; Torres S; Haenni AL; Díaz FJ
    Adv Virus Res; 2010; 77():1-39. PubMed ID: 20951868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.